Business · 28/08/2003Updated: 10/17/2026 · 1 min read
FDA Approves Supplemental New Animal Drug Application for Etodolac in Dogs
Summary
The FDA is amending its regulations to reflect the approval of a supplemental new animal drug application for a 500-mg tablet size of etodolac, a pain reliever, for oral use in dogs, filed by Fort Dodge Animal Health, a division of American Cyanamid Co.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →